Versanis Bio

Versanis Bio was established to develop first-in-class medicines that address medical conditions prevalent in older adults. Versanis’ lead program is bimagrumab being advanced in Phase 2 studies with a goal of helping overweight and obese adults achieve and maintain a healthy body composition.

Headquarters New York, NY
Pipeline Status Phase 2